Curis

Curis is a drug development company dedicated to leveraging its innovative signaling pathway drug technology to create novel targeted small molecule drug candidates for cancer. As Curis expands its drug development efforts in the cancer field through its proprietary targeted cancer programs, it is utilizing its prior experience in targeted signaling pathways to develop the next generation of targeted cancer therapies.